Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label Phase II Clinical Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate to Severe Atopic Dermatitis

NCT06700499 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT06700499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label Phase II Clinical Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate to Severe Atopic Dermatitis
Lead sponsor
Akeso
Phase
Phase 2
Overall status
Completed
Start date
July 8, 2024
Completion date
September 11, 2025
Enrollment
450 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis